Correlation Between MetaVia and Orgenesis
Can any of the company-specific risk be diversified away by investing in both MetaVia and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MetaVia and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MetaVia and Orgenesis, you can compare the effects of market volatilities on MetaVia and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MetaVia with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of MetaVia and Orgenesis.
Diversification Opportunities for MetaVia and Orgenesis
Poor diversification
The 3 months correlation between MetaVia and Orgenesis is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding MetaVia and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and MetaVia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MetaVia are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of MetaVia i.e., MetaVia and Orgenesis go up and down completely randomly.
Pair Corralation between MetaVia and Orgenesis
Given the investment horizon of 90 days MetaVia is expected to generate 0.47 times more return on investment than Orgenesis. However, MetaVia is 2.15 times less risky than Orgenesis. It trades about -0.12 of its potential returns per unit of risk. Orgenesis is currently generating about -0.13 per unit of risk. If you would invest 408.00 in MetaVia on September 22, 2024 and sell it today you would lose (232.00) from holding MetaVia or give up 56.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 67.72% |
Values | Daily Returns |
MetaVia vs. Orgenesis
Performance |
Timeline |
MetaVia |
Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
MetaVia and Orgenesis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MetaVia and Orgenesis
The main advantage of trading using opposite MetaVia and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MetaVia position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.MetaVia vs. Dogwood Therapeutics, | MetaVia vs. Eupraxia Pharmaceuticals Common | MetaVia vs. CERo Therapeutics Holdings | MetaVia vs. Opus Genetics, |
Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |